Instil Bio Stock Today
| TIL Stock | USD 10.41 0.18 1.70% |
Performance0 of 100
| Odds Of DistressOver 64
|
Instil Bio is selling for 10.41 as of the 19th of April 2024. This is a -1.7 percent decrease since the beginning of the trading day. The stock's lowest day price was 10.34. Instil Bio has more than 64 % chance of experiencing financial distress in the next few years of operation. It also generated negative returns for investors over the last 90 days. Equity ratings for Instil Bio are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 20th of January 2024 and ending today, the 19th of April 2024. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 19th of March 2021 | Category Healthcare | Classification Health Care |
Instil Bio, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of patients with cancer. The company was incorporated in 2018 and is headquartered in Dallas, Texas. Instil Bio operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. The company has 6.5 M outstanding shares of which 8.75 K shares are at this time shorted by investors with about 0.62 days to cover. More on Instil Bio
Moving together with Instil Stock
| 0.65 | EOLS | Evolus Inc Financial Report 14th of May 2024 | PairCorr |
| 0.67 | EWTX | Edgewise Therapeutics Financial Report 9th of May 2024 | PairCorr |
Moving against Instil Stock
| 0.41 | LPTX | Leap Therapeutics Financial Report 20th of May 2024 | PairCorr |
Follow Valuation Options Odds of Bankruptcy
Financial Report 9th of May 2024
Instil Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Instil Bio's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Instil Bio or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| CEO | Deion Campbell | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Old Names | [TIPTEL, Trilogy International Limited] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NASDAQ Composite, NASDAQ Composite Total, NASDAQ Health Care, Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation Analysts covering Instil Bio report their recommendations after researching Instil Bio's financial statements, talking to executives and customers, or listening in on Instil Bio's conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering Instil Bio. The Instil consensus assessment is calculated by taking the average forecast from all of the analysts covering Instil Bio. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Financial Strength Based on the analysis of Instil Bio's profitability, liquidity, and operating efficiency, Instil Bio is not in a good financial situation at this time. It has a very high odds of going through financial crisis in May. Financial strength of Instil Bio is based on its profitability, leverage, liquidity, source of funds, and operating efficiency.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Instil Bio's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Instil Bio's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Instil Bio's financial leverage. It provides some insight into what part of Instil Bio's total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Instil Bio (TIL) is traded on NASDAQ Exchange in USA. It is located in 3963 Maple Avenue, Dallas, TX, United States, 75219 and employs 49 people. Instil Bio is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Micro-Cap' category with a total capitalization of 68.84 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Instil Bio's market, we take the total number of its shares issued and multiply it by Instil Bio's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Instil Bio runs under Biotechnology sector within Health Care industry. The entity has 6.5 M outstanding shares of which 8.75 K shares are at this time shorted by investors with about 0.62 days to cover.
Instil Bio has about 354.61 M in cash with (82.03 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.73.
Check Instil Bio Probability Of Bankruptcy
Ownership AllocationThe market capitalization of Instil Bio is $68.84 Million. Over half of Instil Bio's outstanding shares are owned by outside corporations. These outside corporations are typically referred to as corporate investors that purchase positions in a given instrument to benefit from reduced trade commissions. Consequently, these institutions are subject to different rules and regulations than regular investors in Instil Bio. Please watch out for any change in the institutional holdings of Instil Bio as this could mean something significant has changed or is about to change at the company. Note, that even with negative profits, if the true value of the firm is larger than the current market value, you may still be able to generate positive returns on investment in this company.
Check Instil Ownership Details
Instil Stock Price Odds Analysis
Proceeding from a normal probability distribution, the odds of Instil Bio jumping above the current price in 90 days from now is about 86.78%. The Instil Bio probability density function shows the probability of Instil Bio stock to fall within a particular range of prices over 90 days. Considering the 90-day investment horizon Instil Bio has a beta of 0.2227. This usually implies as returns on the market go up, Instil Bio average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Instil Bio will be expected to be much smaller as well. Additionally, instil Bio has an alpha of 0.5616, implying that it can generate a 0.56 percent excess return over NYSE Composite after adjusting for the inherited market risk (beta).
Based on a normal probability distribution, the odds of Instil Bio to move above the current price in 90 days from now is about 86.78 (This Instil Bio probability density function shows the probability of Instil Stock to fall within a particular range of prices over 90 days) .
Instil Stock Institutional Holders
Institutional Holdings refers to the ownership stake in Instil Bio that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Instil Bio's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Instil Bio's value.| Instituion | Recorded On | Shares | |
| Citadel Advisors Llc | 2023-09-30 | 46.6 K | |
| Blackrock Inc | 2023-12-31 | 37.6 K | |
| Two Sigma Advisers, Llc | 2023-12-31 | 36.8 K | |
| Geode Capital Management, Llc | 2023-12-31 | 31.4 K | |
| Squarepoint Ops Llc | 2023-12-31 | 27.8 K | |
| Anson Funds Management Lp | 2023-12-31 | 17.3 K | |
| Acadian Asset Management Llc | 2023-12-31 | 14 K | |
| State Street Corporation | 2023-12-31 | 12.6 K | |
| Morgan Stanley - Brokerage Accounts | 2023-12-31 | 5.1 K | |
| Curative Ventures V Llc | 2023-12-31 | 1.9 M | |
| Jacobs Levy Equity Management, Inc. | 2023-09-30 | 867.3 K |
Instil Bio Historical Income Statement
Instil Bio Income Statement is one of the three primary financial statements used for reporting Instil's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Instil Bio revenue and expense. Instil Bio Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At this time, Instil Bio's Total Operating Expenses is quite stable compared to the past year. View More FundamentalsInstil Stock Against Markets
Picking the right benchmark for Instil Bio stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Instil Bio stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Instil Bio is critical whether you are bullish or bearish towards Instil Bio at a given time. Please also check how Instil Bio's historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Instil Bio without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Headlines Timeline Now
Headlines TimelineStay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |
| All Next | Launch Module |
Instil Bio Corporate Directors
Instil Bio corporate directors refer to members of an Instil Bio board of directors. The board of directors generally takes responsibility for the Instil Bio's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Instil Bio's board members must vote for the resolution. The Instil Bio board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.| John Rickard | Director | Profile | |
| Aloke Banerjee | CFO, Director - Finance, Executive Director | Profile | |
| Paul Newfield | Director | Profile | |
| Fiona Oliver | Director | Profile |
How to buy Instil Stock?
Before investing in Instil Bio, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Instil Bio. To buy Instil Bio stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of Instil Bio. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase Instil Bio stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located Instil Bio stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased Instil Bio stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Instil Bio, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy Instil Stock please use our How to Invest in Instil Bio guide.
Already Invested in Instil Bio?
The danger of trading Instil Bio is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Instil Bio is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Instil Bio. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Instil Bio is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Instil Bio is a strong investment it is important to analyze Instil Bio's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Instil Bio's future performance. For an informed investment choice regarding Instil Stock, refer to the following important reports: Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Instil Bio. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product. For more information on how to buy Instil Stock please use our How to buy in Instil Stock guide.You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.
Complementary Tools for Instil Stock analysis
When running Instil Bio's price analysis, check to measure Instil Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Instil Bio is operating at the current time. Most of Instil Bio's value examination focuses on studying past and present price action to predict the probability of Instil Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Instil Bio's price. Additionally, you may evaluate how the addition of Instil Bio to your portfolios can decrease your overall portfolio volatility.
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences |
Is Instil Bio's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Instil Bio. If investors know Instil will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Instil Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (24.00) | Return On Assets (0.14) | Return On Equity (0.53) |
The market value of Instil Bio is measured differently than its book value, which is the value of Instil that is recorded on the company's balance sheet. Investors also form their own opinion of Instil Bio's value that differs from its market value or its book value, called intrinsic value, which is Instil Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Instil Bio's market value can be influenced by many factors that don't directly affect Instil Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Instil Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Instil Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Instil Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.